XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar FSaucy (99.96) Submitted: 7/22/2010 3:48:38 PM : Outperform Start Price: $6.19 XNPT Score: -25.64

Following SAC Capital on this.

Featured Broker Partners


Advertisement